Search Results - Natalie Callander
- Showing 1 - 5 results of 5
-
1
S203: QUADRUPLET INDUCTION THERAPY, ASCT AND MRD-MODULATED CONSOLIDATION AND TREATMENT CESSATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA: FINAL ANALYSIS OF THE MASTER TRIAL by Luciano Costa, Eva Medvedova, Sarabh Chhabra, Bhagirathbhai Dholaria, Binod Dhakal, Kelly Godby, Rebecca Silberman, Susan Bal, Anita D’souza, Smith Giri, Timothy Schmidt, James Omel, Parameswaran Hari, Natalie Callander
Published in HemaSphere (2023-08-01)Get full text
Article -
2
P905: PATIENT REPORTED OUTCOMES IN TRIPLE CLASS EXPOSED, RELAPSED/REFRACTORY MULTIPLE MYELOMA (TCE RRMM) PATIENTS IN KARMMA 3 TRIAL (PHASE 3 RCT): IDECABTAGENE VICLEUCEL (IDE-CEL)... by Michel Delforge, Krina Patel, Laurie Eliason, Devender Dhanda, Ling Shi, Shien Guo, Thomas Marshall, Bertrand Arnulf, Michele Cavo, Ajay Nooka, Salomon Manier, Natalie Callander, Sergio Giralt, Hermann Einsele, Sikander Ailawadhi, Mihaela Popa Mckiver, Mark Cook, Paula Rodríguez-Otero
Published in HemaSphere (2023-08-01)Get full text
Article -
3
P913: LOW-DOSE BELANTAMAB MAFODOTIN (BELAMAF) IN COMBINATION WITH NIROGACESTAT VS BELAMAF MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PHASE 1/2 DREAMM... by Natalie Callander, Paul Richardson, Marek Hus, Vincent Ribrag, Joaquín Martinez-Lopez, Kihyun Kim, Jae Hoon Lee, Meletios A. Dimopoulos, Fredrik Schjesvold, Thierry Facon, Jae-Cheol Jo, Chang-Ki Min, Michał Mielnik, Shinta Cheng, Mary Smith, Caroline J. Breitbach, Chris Brawley, Harjeet Sembhi, John Lamacchia, Sebastian Grosicki
Published in HemaSphere (2023-08-01)Get full text
Article -
4
S195: IDECABTAGENE VICLEUCEL (IDE-CEL) VS STANDARD REGIMENS IN PATIENTS WITH TRIPLE-CLASS–EXPOSED (TCE) RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM): A KARMMA-3 ANALYSIS IN HIGH... by Krina Patel, Paula Rodríguez-Otero, Salomon Manier, Rachid Baz, Marc S. Raab, Michele Cavo, Natalie Callander, Luciano Costa, Philippe Moreau, Scott Solomon, Christine Chen, Noopur Raje, Christof Scheid, Michel Delforge, Jeremy Larsen, Thomas Pabst, Kenshi Suzuki, Anna Truppel-Hartmann, Zhihong Yang, Julia Piasecki, Jasper Felten, Andrea Caia, Mark Cook, Sergio Giralt, Maria-Victoria Mateos
Published in HemaSphere (2023-08-01)Get full text
Article -
5
Selinexor, daratumumab, and dexamethasone in patients with relapsed or refractory multiple myeloma by Cristina Gasparetto, Suzanne Lentzsch, Gary Schiller, Natalie Callander, Sascha Tuchman, Christine Chen, Darrell White, Rami Kotb, Heather Sutherland, Michael Sebag, Muhamed Baljevic, William Bensinger, Richard LeBlanc, Chris Venner, Nizar Bahlis, Adriana Rossi, Noa Biran, Heidi Sheehan, Jean‐Richard Saint‐Martin, Dane Van Domelen, Kazuharu Kai, Jatin Shah, Sharon Shacham, Michael Kauffman, Brea Lipe
Published in eJHaem (2021-02-01)Get full text
Article
